OpenAlex
PricingAboutJobs
Log inGet started
Work

AZD4573 in Combination with CHOP Increases Combination Benefit in Preclinical Peripheral T-Cell Lymphomas Models

HTML

Year: 2023
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2023-179419
Authors: Danielle S Potter, India Ott, Jamal Saeh, Richard Olsson, Stephen Fawell, Lisa Drew, Justine Roderick-Richardson
Institution: AstraZeneca (United States)
Language: English

Topic: Lymphoma Diagnosis and Treatment
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: AZD4573, CDK9 inhibitor, CHOP chemotherapy, peripheral T-cell lymphoma, Mcl-1, Bfl-1, c-Myc, Bcl-2 family proteins, RNA polymerase II phosphorylation, apoptosis, combination therapy, relapsed/refractory lymphoma, xenograft models, AlCl, peripheral T-cell lymphoma, not otherwise specified
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4389220175
Cites:
Cited by: 3
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security